Amit B. Shah is CHIEF FINANCIAL OFFICER of Oncotelic Therapeutics, Inc.. Currently has a direct ownership of 358,837 shares of OTLC, which is worth approximately $7,176. The most recent transaction as insider was on Jul 08, 2021, when has been sold 298,837 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 359K
0% 3M change
0% 12M change
Total Value Held $7,176

Amit B. Shah Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 08 2021
BUY
Grant, award, or other acquisition
-
298,837 Added 45.44%
358,837 Common Stock
Nov 24 2020
BUY
Open market or private purchase
$1,562 $0.19 p/Share
8,220 Added 12.05%
60,000 Common Stock
Nov 23 2020
BUY
Open market or private purchase
$3,817 $0.19 p/Share
20,088 Added 27.95%
51,780 Common Stock
Nov 20 2020
BUY
Open market or private purchase
$6,338 $0.2 p/Share
31,692 Added 50.0%
31,692 Common Stock
ABS

Amit B. Shah

CHIEF FINANCIAL OFFICER
Agoura Hills,, CA

Track Institutional and Insider Activities on OTLC

Follow Oncotelic Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OTLC shares.

Notify only if

Insider Trading

Get notified when an Oncotelic Therapeutics, Inc. insider buys or sells OTLC shares.

Notify only if

News

Receive news related to Oncotelic Therapeutics, Inc.

Track Activities on OTLC